Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Feb 7, 2008
app pub date -
Sep 19, 2005
filing date -
Sep 17, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention describes a novel form of the MCIP protein, a 38 kDa version (MCIP-1-38) that predominates in the human heart, the upregulation of which is strongly suggested for the treatment or prevention of heart disease. The present invention provides for methods of treating and preventing cardiovascular diseases, in particular pathological cardiac hypertrophy and chronic heart failure, by applying a modulator of MCIP-1-38. The present invention also provides for methods of screening to find modulators of MCIP-1-38 and inhibitors of cardiac hypertrophy and heart failure.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully